Medical/Pharmaceuticals

Antengene Announces Five Upcoming Presentations at the 2022 American Association for Cancer Research Annual Meeting

* Posters Showcase Early-Stage Clinical and Preclinical Pipeline. * Focus on ATG-037, ATG-018, ATG-022, ATG-012 and ATG-008. SHANGHAI and HONG KONG, March 9, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company ...

2022-03-09 20:00 5120

Pudu Robotics Helps Hong Kong Combat Covid-19 Pandemic

The firm once again participates in the fight against the pandemic by donating robots that support contactless delivery and automatic disinfection SHENZHEN, China, March 9, 2022 /PRNewswire/ -- Pudu Robotics , the global leader in commercial service robots, has dona...

2022-03-09 20:00 3517

Antengene Announces XPOVIO® Approved by the TGA in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Triple Class-Refractory Multiple Myeloma

-  XPOVIO®, in combination with bortezomib and dexamethasone (XBd), gives patients with relapsed and/or refractory multiple myeloma, a new treatment option. -  XPOVIO®, in combination with dexamethasone (Xd), gives patients with triple class refractory multiple myeloma, a new treatment option.  ...

2022-03-09 19:08 4127

Cappfinity and Lexxic partnership helps organisations embrace neurodiversity in the workplace

LONDON, March 9, 2022 /PRNewswire/ -- HR tech firm, Cappfinity, has announced a new partnership with specialist neurodiversity consultancy, Lexxic, to help businesses create a culture that enables neurodivergent talent to flourish. Operating since 2007, Lexxic was founded by Chartered Occupationa...

2022-03-09 16:55 2373

Adagene Announces Four Poster Presentations on Robust Preclinical Pipeline of Antibody-Based Therapeutics at Upcoming American Association for Cancer Research (AACR) Annual Meeting

* New IND-enabling programs reinforce commitment to build a deep, broad and differentiated pipeline that transforms cancer immunotherapy leveraging company's AI-powered platform - * SAFEbody® precision masking technology integrated across antibody-based modalities in POWERbody® candidates, de...

2022-03-09 10:21 4192

Alphamab Oncology to Present Clinical Data of KN026 Combined with KN046 in HER2-positive Solid Tumors at AACR 2022

SUZHOU, China, March 9, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that data from phase II clinical study (KN026-203) of KN026 (HER2 bispecific antibody) combined with KN046 (PD-L1/CTLA-4 bispecific antibody) will be presented by E- poster at the 113th American Associa...

2022-03-09 09:14 2944

Omega Healthcare Acquires Reventics, a Physician Focused CDI and RCM Company

BOCA RATON, Fla., March 9, 2022 /PRNewswire/ -- Omega Healthcare, a leading healthcare management solutions partner supporting the broad healthcare ecosystem, today announced its acquisition of Reventics, aDenver, CO based company. Reventics is a clinical documentation improvement ("CDI") and re...

2022-03-09 06:38 2389

FIRST SURGERIES COMPLETED WITH PATIENT-SPECIFIC 3D PRINTED IMPLANTS PRODUCED AT THE LIMACORPORATE PROMADE POINT OF CARE CENTER AT HOSPITAL FOR SPECIAL SURGERY

UDINE, Italy, March 9, 2022 /PRNewswire/ -- LimaCorporate S.p.A., leading global orthopedics manufacturer, and Hospital for Special Surgery (HSS), consistently ranked number one in orthopedics globally by Newsweek and nationally byU.S. News & World Report in the U.S., today announced a new miles...

2022-03-09 06:16 2867

MediTrust Health invited three women who are fighting with diseases to share their views for March 8th Women's Day

SHANGHAI, March 8, 2022 /PRNewswire/ -- As the Women's Day is approaching, MediTrust Health invited three women who are fighting with diseases to share their views on one question - why do we need to live a sparkling life. We hope their answers will inspire and encourage those who are struggling ...

2022-03-08 18:22 2456

SNIPR BIOME announces opening of new BSL2/GMO2-classified laboratory in Copenhagen, Denmark

COPENHAGEN, Denmark, March 8, 2022 /PRNewswire/ -- SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, is opening a 175 square meter state-of-the-art BSL2/GMO2-classified laboratory inCopenhagen. The new facilities will be among the largest GMO2 laboratories in Scandinavia and...

2022-03-08 15:31 2097

Nippon Express USA Acquires GDP Certification for CFS in Los Angeles and New York

TOKYO, March 8, 2022 /PRNewswire/ -- Nippon Express USA, Inc. (hereinafter "NX USA"), a group company of Nippon Express Holdings, Inc., has obtained Good Distribution Practice (GDP) certification for forwarding operations, inclusive of temporary storage, at temperature-controlled facilities in it...

2022-03-08 14:00 3601

Suvoda Unveils New Brand to Reflect Expanded Focus in Complex Clinical Trial Management

Alongside brand refresh, leading clinical trial technology company announces eConsent and eCOA offerings to better support the patient clinical trial journey. PHILADELPHIA, March 8, 2022 /PRNewswire/ -- Suvoda LLC today launched a refreshed brand, to better reflect its leadership position as a g...

2022-03-08 08:00 2396

Academic Stress and Emotional Well-Being in Students with Colour Vision Deficiency

KUALA LUMPUR, Malaysia, March 7, 2022 /PRNewswire/ -- Head of Optometry and Vision Science Programme from the Faculty of Health Sciences, Universiti Kebangsaan Malaysia (UKM), Prof DrSharanjeet Kaur Malkeet Singh found that students with congenital colour vision deficiency have emotional problems...

2022-03-07 10:00 4937

HCmed, Formosa Laboratories, and Formosa Pharmaceuticals Signed MoU to Form a Global CDMO for Inhalation Treatment Drugs

TAIPEI, March 7, 2022 /PRNewswire/ -- HCmed Innovations, Co., Ltd. (HCmed) announced that it has formed a strategic alliance with Formosa Laboratories, Inc. (TPEx: 4746) and Formosa Pharmaceuticals, Inc. (TPEx: 6838) to expand its business in the inhalation treatment field, providing contract dev...

2022-03-07 09:00 2869

AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer

GUANGZHOU, China, March 7, 2022 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announce that Dr. Marina Bibikova has come on board as Chief Scientific Officer (CSO). She will be responsible for cancer early detection technolo...

2022-03-07 09:00 3268

New Robotic Assisted Transperineal Needle-Guidance System for Prostate Biopsy and Cancer Ablations Received U.S FDA 510(k) Clearance

SINGAPORE, March 5, 2022 /PRNewswire/ -- Biobot Surgical is excited to announce U.S. FDA 510(k) clearance of the iSR'obot Mona Lisa 2.0. The new robotic assisted transperineal needle-guidance system allows urologists to plan and position a single needle or multiple needles during image-guided dia...

2022-03-05 20:00 4570

Scientific leaders signal major breakthroughs in elimination of cervical and anal cancers

GENEVA, March 4, 2022 /PRNewswire/ -- To mark International HPV Awareness Day March 4th 2022, the International Papillomavirus Society (IPVS) has warmly welcomed two major advances in the elimination of cervical and anal cancers.

2022-03-04 08:01 4526

CNN's Vital Signs explores the future of medicine

HONG KONG, March 3, 2022 /PRNewswire/ -- From personalized vaccines to lab-grown organs and AI-powered medical devices, the future of medicine is happening right now in labs across the world. This month on CNN's 'Vital Signs' , Chief Medical Correspondent Dr. Sanjay Gupta ...

2022-03-03 10:13 4019

Sequential Skin debuts Sequential Bio - the world's first in-vivo microbiome testing solution for skin, hair, and personal product industries.

LONDON, NEW YORK and SINGAPORE, March 3, 2022 /PRNewswire/ -- Sequential Skin Ltd, a leading microbiome company today announced the debut ofSequential Bio – a novel "in-vivo" microbiome testing solution uniquely tailored for companies across skincare, haircare, and p...

2022-03-03 07:55 3491

Zhongshan Chenxinghai Hospital, Hong Kong Integrated Oncology Centre and healthcare distributor DCH Auriga partner to provide Hong Kong-approved medical treatments to GBA patients

HONG KONG, March 2, 2022 /PRNewswire/ -- On 2 March 2022, Zhongshan Chenxinghai Hospital,a leading Hong Kong cancer treatment centre, Hong Kong Integrated Oncology Centre ("HKIOC"), and healthcare distributor DCH Auriga announced their strategic cooperation in support of a National State Council ...

2022-03-02 20:02 4705
1 ... 338339340341342343344 ... 382

Week's Top Stories